Jane Street’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $621K | Sell |
36,598
-415,506
| -92% | -$6.64M | ﹤0.01% | 7517 |
|
|
2026
Q1 | $6.7M | Sell |
452,104
-458,633
| -50% | -$6.7M | ﹤0.01% | 3086 |
|
|
2025
Q4 | $14.5M | Buy |
910,737
+233,484
| +34% | +$3.31M | ﹤0.01% | 1905 |
|
|
2025
Q3 | $7.48M | Buy |
677,253
+210,626
| +45% | +$2.3M | ﹤0.01% | 2815 |
|
|
2025
Q2 | $3.95M | Buy |
466,627
+154,071
| +49% | +$1.24M | ﹤0.01% | 3340 |
|
|
2025
Q1 | $2.51M | Buy |
312,556
+89,911
| +40% | +$728K | ﹤0.01% | 4002 |
|
|
2024
Q4 | $2M | Sell |
222,645
-241,356
| -52% | -$1.97M | ﹤0.01% | 4095 |
|
|
2024
Q3 | $3.4M | Buy |
464,001
+216,773
| +88% | +$1.34M | ﹤0.01% | 3497 |
|
|
2024
Q2 | $1.41M | Buy |
247,228
+137,412
| +125% | +$724K | ﹤0.01% | 5113 |
|
|
2024
Q1 | $550K | Sell |
109,816
-472,671
| -81% | -$3.21M | ﹤0.01% | 6488 |
|
|
2023
Q4 | $5.24M | Buy |
582,487
+283,030
| +95% | +$2.33M | ﹤0.01% | 2781 |
|
|
2023
Q3 | $2.33M | Sell |
299,457
-70,302
| -19% | -$688K | ﹤0.01% | 3798 |
|
|
2023
Q2 | $3.58M | Buy |
369,759
+3,333
| +0.9% | +$34.6K | ﹤0.01% | 3220 |
|
|
2023
Q1 | $4.02M | Buy |
366,426
+232,868
| +174% | +$2.05M | ﹤0.01% | 2748 |
|
|
2022
Q4 | $577K | Sell |
133,558
-272,433
| -67% | -$1.58M | ﹤0.01% | 5877 |
|
|
2022
Q3 | $3.05M | Sell |
405,991
-183,105
| -31% | -$1.58M | ﹤0.01% | 3424 |
|
|
2022
Q2 | $5.92M | Buy |
589,096
+250,115
| +74% | +$2.8M | ﹤0.01% | 2418 |
|
|
2022
Q1 | $4.2M | Sell |
338,981
-148,886
| -31% | -$2.3M | ﹤0.01% | 3335 |
|
|
2021
Q4 | $11.2M | Buy |
487,867
+136,431
| +39% | +$3.23M | ﹤0.01% | 1750 |
|
|
2021
Q3 | $5.76M | Buy |
351,436
+71,466
| +26% | +$1.13M | ﹤0.01% | 2513 |
|
|
2021
Q2 | $3.63M | Buy |
279,970
+249,859
| +830% | +$3.18M | ﹤0.01% | 3210 |
|
|
2021
Q1 | $391K | Sell |
30,111
-220,972
| -88% | -$3.21M | ﹤0.01% | 7240 |
|
|
2020
Q4 | $3.47M | Buy |
251,083
+103,090
| +70% | +$1.5M | ﹤0.01% | 2610 |
|
|
2020
Q3 | $2.18M | Buy |
147,993
+40,817
| +38% | +$591K | ﹤0.01% | 2900 |
|
|
2020
Q2 | $1.74M | Buy |
+107,176
| New | +$1.72M | ﹤0.01% | 3256 |
|
|
2020
Q1 | – | Sell |
-26,024
| Closed | -$459K | – | 5275 |
|
|
2019
Q4 | $527K | Buy |
+26,024
| New | +$240K | ﹤0.01% | 3624 |
|
|
2018
Q4 | – | Sell |
-27,358
| Closed | -$182K | – | 4911 |
|
|
2018
Q3 | $182K | Buy |
+27,358
| New | +$153K | ﹤0.01% | 4725 |
|
|
2017
Q4 | – | Sell |
-10,041
| Closed | -$63K | – | 4542 |
|
|
2017
Q3 | $63K | Buy |
+10,041
| New | +$63.3K | ﹤0.01% | 4320 |
|
|
2017
Q2 | – | Sell |
-21,113
| Closed | -$155K | – | 4304 |
|
|
2017
Q1 | $155K | Buy |
+21,113
| New | +$97.5K | ﹤0.01% | 3915 |
|
Other funds holding AUPH
TCM
NMC
Jane Street's AUPH Position: Q2 2026 in Review
Jane Street reduced its Aurinia Pharmaceuticals (AUPH) stake by 92% in Q2 2026, selling an estimated $6.64M and leaving 36,598 shares worth $621K. The position accounts for ﹤0.01% of the portfolio, ranked #7517.
Jane Street first reported a position in AUPH in Q1 2017 and has held it in 29 quarters since. The position peaked at $14.5M in Q4 2025. 283 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.
- Jane Street held 36,598 shares of Aurinia Pharmaceuticals worth $621K as of Q2 2026.
- Jane Street sold 415,506 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $6.64M.
- Aurinia Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #7517 holding.
- Jane Street first reported a position in Aurinia Pharmaceuticals in Q1 2017 and has held it in 29 quarters since.
- Jane Street's Aurinia Pharmaceuticals position peaked at $14.5M in Q4 2025.
- 283 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.